Executive Albert Bourla News Today

Pfizer Inc. said late Thursday that its board of directors declared an increase in the company’s quarterly dividend to 42 cents a share, from 41 cents a...

Pfizer Inc.’s stock slid 7% premarket Wednesday, after the drug company set guidance for 2024 that lagged consensus. Pfizer, which is hosting an investor day...

Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic. The company, which reported more than $100 billion in revenue in 2022 due to the lift from Covid-19 vaccine and therapeutic sales, sees 2024 revenues of between $58.5 billion and $61.5 billion, according to its presentation.

Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic.

Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic.

By Sabela Ojea Pfizer is launching a multi-year cost-cutting plan as it slashes its revenue expectations for the year due to lower sales related to Covid-19. The healthcare giant on Friday...

Pfizer on Tuesday said it will launch a cost-cutting program if its COVID-19 vaccine and antiviral treatment keep underperforming expectations in the coming months due to plunging demand.

If COVID vaccinations are very low this year, the company will scale back its investments

The drugmaker would pay $229 a share in cash for the biotech cancer specialist

By Bhanvi Satija and Michael Erman